Premature ovarian failure

Abstract
The past 2 years have seen progress in our understanding of the process of premature ovarian failure with identification of molecular causes and clarification of the auto-immune targets within the ovary. With the knowledge that most women with premature ovarian failure have ovarian follicles on ultrasonography, we eagerly await the next therapeutic landmark — the application of the preservation or in-vitro maturation of ova.

This publication has 0 references indexed in Scilit: